Background
Rhinoscleroma is an unusual chronic granulomatous disease of the upper airways. It commonly affects the nasal cavity (95% to 100%), but the nasopharynx (18% to 43%), larynx (15% to 40%), trachea (12%), and bronchi (2% to 7%). It is caused by Klebsiella rhinoscleromatis. It is not highly contagious.
Rhinoscleroma has been divided into 3 or 4 stages:
Catarrhal/atrophic
Granulomatous
Sclerotic stageThe catarrhal stage begins with a nonspecific rhinitis, which evolves into purulent, fetid rhinorrhea and crusting, lasting for weeks or months. The granulomatous stage leads to the nasal mucosa becoming bluish red and granular with intranasal rubbery nodules or polyps. Epistaxis (bloody nose) associated with nasal enlargement, deformity, and destruction of the nasal cartilage is noted (Hebra nose). This damage may progress to anosmia, anesthesia of the soft palate, enlargement of the uvula, dysphonia, and various degrees of airway obstruction. The fibrotic stage is characterized by sclerosis and fibrosis.
SYNONYMS Mikulicz disease AGE RANGE-MEDIAN Second and third decades SEX (M:F)Slight female GEOGRAPHYCentral and Eastern Europe
Low socioeconomic environments of Central and South America, Africa, the Middle East, Philippines, and IndiaRare in the United States
EPIDEMIOLOGIC ASSOCIATIONS CHARACTERIZATION Poor hygiene, crowded living conditions, and malnutrition Increase the risk for transmission
DISEASE ASSOCIATIONS CHARACTERIZATION AIDS and other conditions with T-cell deficiency
PATHOGENESIS CHARACTERIZATION Klebsiella rhinoscleromatis Gram-negative, encapsulated, nonmotile, diplobacillus member of the family Enterobacteriaceae
Contracted directly by droplets or by contamination of material that is subsequently inhaled Probably begins in areas of epithelial transition, as seen in the vestibule of the nose, subglottic area of the larynx, or between the nasopharynx and oropharynx Cellular and humoral immunity Cellular immunity is impaired in these patients however, the humoral immunity is preserved
CD4–CD8 ratio within the lesion is altered, showing decreased CD4 lymphocytes and increased CD8 lymphocytes, possibly inducing a diminished T-cell response
The macrophages are not fully activated
Mucopolysaccharides of the bacterial capsule probably contribute to inhibition of phagocytosis
LABORATORY/RADIOLOGIC/OTHER TESTS CHARACTERIZATION Laboratory Markers CulturesA positive culture in MacConkey agar is diagnostic of rhinoscleroma, but cultures are positive in only 50% to 60% of cases
HISTOLOGICAL TYPES CHARACTERIZATION General Three stages, corresponding to the clinical stages
Only the granulomatous stage has diagnostic changes
Catarrhal/atrophic stageSquamous metaplasia and a nonspecific subepithelial infiltrate of polymorphonuclear leukocytes with granulation tissue Granulomatous stageDiagnostic features are found in the granulomatous stage
Chronic inflammatory cells, Russell bodies, and pseudoepitheliomatous hyperplasia, groups of large vacuolated histiocytes containing the Klebsiella rhinoscleromatis (Mikulicz cells)
If numerous, they can be seen with hematoxylin-eosin stains, but may require periodic acid–Schiff, silver impregnation, or immunohistochemical stains for confirmation and identification
Sclerotic stageExtensive fibrosis, which may lead to stenosis and disfiguration. VARIANTS
SPECIAL STAINS/IMMUNOPEROXIDASE/OTHER CHARACTERIZATION Special stains Bacteria seen by PAS,Giemsa, Gram, and silver stains Electron microscopy (EM) Large phagosomes filled with bacilli and surrounded by a finely granular or fibrillar material arranged radially
Represents accumulation of antibodies on the bacterial surface (type A granules), as well as aggregates of bacterial mucopolysaccharides surrounded by antibodies (type B granules)
DIFFERENTIAL DIAGNOSIS KEY DIFFERENTIATING FEATURES Infectious granulomatous processes Bacterial (tuberculosis, actinomycosis, syphilis, and leprosy)
Fungal (histoplasmosis, blastomycosis, paracoccidioidomycosis, and sporotrichosis)
Parasitic (mucocutaneous leishmaniasis)
Sarcoidosis Vasculitis Wegener granulomatosis Neoplastic diseases Lymphoma Extranodal Rosai-Dorfman disease
PROGNOSIS AND TREATMENT CHARACTERIZATION Prognostic Factors Survival It is rarely lethal, unless it obstructs the airways Recurrence Owing to a high incidence of recurrence, prolonged antibiotic therapy over months to years is necessary Treatment Tetracycline is the drug of choice
Other anbiotics inlude ciprofloxacin and rifampin
Steroids can improve the acute inflammatory symptoms
SurgerySurgery and laser therapy are required to treat airway compromise and tissue deformity Arch Pathol Lab Med 2001;125:157–158.
Arch Pathol Lab Med 2001;125:159-160.
Last Updated 11/8/2001
Send mail to The Doctor's Doctor with questions or comments about this web site.
Copyright © 2004 The Doctor's Doctor